Insulin Analogues

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023

Untitled work

Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., & Bolli, G. B. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2142 · Cited by 818

Intermittent High Glucose Enhances Apoptosis Related to Oxidative Stress in Human Umbilical Vein Endothelial Cells

Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., & Ceriello, A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2795 · Cited by 772

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739

Standards of Medical Care in Diabetes

(2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s15 · Cited by 688

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Yki‐Järvinen, H., Dressler, A., Ziemen, M., & HOE 901/300s Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1130 · Cited by 573

Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review

DeWitt, D. E., & Hirsch, I. B. (2003) · JAMA · doi:10.1001/jama.289.17.2254 · Cited by 502

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483

The Role of Insulin Glargine and Human Insulin in the Regulation of Thyroid Proliferation Through Mitogenic Signaling

Sheng, X., Yao, K., Shao, A., Tu, S., Zhang, X., Chen, T., & Yao, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00594 · Cited by 7

Effects of treatment with lispro and neutral protamine Hagedorn insulins on serum fructosamine and postprandial blood glucose concentrations in dogs with clinically well-controlled diabetes mellitus and postprandial hyperglycemia

Bertalan, A. V., Drobatz, K. J., & Hess, R. S. (2020) · American Journal of Veterinary Research · doi:10.2460/ajvr.81.2.153 · Cited by 7

Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real‐world patients with type 1 and type 2 diabetes

Oya, J., Nakagami, T., Hasegawa, Y., Katamine, A., Kondo, Y., & Babazono, T. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13559 · Cited by 7

A centennial review of discoveries and advances in diabetes: Children and youth

Mistry, S., Tonyushkina, K. N., Benavides, V. C., Choudhary, A., Huerta‐Saenz, L., Patel, N. S., Mahmud, F. H., Libman, I. M., & Sperling, M. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13392 · Cited by 12

Combining Basal-Bolus Insulin Infusion for Tight Postprandial Glucose Control: An in Silico Evaluation in Adults, Children, and Adolescents

Revert, A., Rossetti, P., Calm, R., Vehı́, J., & Bondía, J. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400617 · Cited by 7

Application of Molecular Biology and Genetics in Endocrinology

Kopp, P. A. (2007) · Endocrine Practice · doi:10.4158/ep.13.5.534 · Cited by 7

Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy

Edwards, K. L., Riche, D. M., Stroup, J. S., Goldman, J. D., Vellurattil, R. P., Cross, L. B., & Kane, M. P. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.9.955 · Cited by 6

Toward Better Understanding of Insulin Therapy by Translation of a PK‐PD Model to Visualize Insulin and Glucose Action Profiles

Schneck, K. B., Tham, L. S., Ertekin, A., & Reviriego, J. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1321 · Cited by 7

New era of therapy for endocrine autoimmune disorders

Oftedal, B. E., & Wolff, A. S. B. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12961 · Cited by 7

Treating the Whole Patient for Optimal Management of Type 2 Diabetes: Considerations for Insulin Therapy

Campos, C. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e3180485a9d · Cited by 7

Diabetes and Stroke: Part two—Treating diabetes and stress hyperglycemia in hospitalized stroke patients

Burroughs, V. J., & Weinberger, J. M. (2006) · Current Cardiology Reports · doi:10.1007/s11886-006-0007-0 · Cited by 7

Managing Hyperglycemia in Hospitalized Patients

Braithwaite, S. S., Mehrotra, H. P., Robertson, B. A., McElveen, L. M., & Thompson, C. L. (2007) · Clinical cornerstone · doi:10.1016/s1098-3597(09)60007-7 · Cited by 7

Role of Devices in Insulin Delivery

Meneghini, L., & McNulty, J. N. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0011 · Cited by 6

One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus

Evans, M., Morgan, A. R., & Bain, S. C. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01061-7 · Cited by 6

The association of long‐acting insulin analogue use versus neutral protamine Hagedorn insulin use and the risk of major adverse cardiovascular events among individuals with type 2 diabetes: A population‐based cohort study

Brunetti, V. C., Yu, O. H. Y., Platt, R. W., & Filion, K. B. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14802 · Cited by 6

The Effect of High-Intensity Interval Exercise on Short-Term Glycaemic Control, Serum Level of Key Mediator in Hypoxia and Pro-Inflammatory Cytokines in Patients with Type 1 Diabetes—An Exploratory Case Study

Hall, B., Żebrowska, A., Sikora, M., Siatkowski, S., & Robins, A. (2023) · Nutrients · doi:10.3390/nu15173749 · Cited by 7

Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings

Pīrāgs, V., El‐Damasy, H., Dąbrowski, M., Gönen, M. S., Račická, E., Martinka, E., Giaconia, J. M., Stefański, A., & On Behalf of the B001 Study Investigators (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.03001.x · Cited by 6

Glycemic control during labor and delivery: a survey of academic centers in the United States

Grant, E. N., & Joshi, G. P. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1972-0 · Cited by 6

Dose–response relationship of insulin glulisine in subjects with type 1 diabetes

Becker, R. H. A., Frick, A. D., Teichert, L., Nosek, L., Heinemann, L., & Rave, K. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01013.x · Cited by 6

From Pancreatic to Non-Pancreatic Insulin: A Miraculous Journey

Anwer, R., AlQumaizi, K. I., Al-Shaqha, W. M., & Khan, F. I. (2015) · International Journal of Biological Chemistry · doi:10.3923/ijbc.2015.302.317 · Cited by 6

IR and IGF-1R expression affects insulin induced proliferation and DNA damage

Othman, E. M., Altabaa, T., Hintzsche, H., & Stopper, H. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.11.011 · Cited by 6

Pharmacodynamics and pharmacokinetics of insulin aspart assessed by use of the isoglycemic clamp method in healthy cats

Pipe‐Martin, H. N., Fletcher, J. M., Gilor, C., & Mitchell, M. A. (2017) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2017.09.002 · Cited by 6

Insulin down-regulates cardioprotective SUR2A in the heart-derived H9c2 cells: A possible explanation for some adverse effects of insulin therapy

Du, Q., Jovanović, S., Sukhodub, A., Ngoi, Y. S., Lal, A., Zheleva, M., & Jovanović, A. (2018) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2018.08.005 · Cited by 6

Systematic Review and Metaanalysis of Short-Acting Insulin Analogues in Patients With Diabetes Mellitus

Leahy, J. L. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70594-7 · Cited by 6

Future directions for insulin therapy and diabetes treatment

Heinemann, L. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(07)80012-0 · Cited by 6

Are Analogue Insulins Superior to Human Insulin in Clinical Practice?

Freeman, J. S. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0104-8 · Cited by 6

Gender-Specific Care of Diabetes

Szalat, A., & Raz, I. (2007) · Women s Health · doi:10.2217/17455057.3.6.735 · Cited by 7

Inpatient Glycemic Control: An Evolving Paradigm

Yalla, N. M., & Reynolds, L. R. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.05.1999 · Cited by 6

Chronic Diseases and Wilderness Activities

Grissom, C. K., & DeLoughery, T. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03228-5.50034-3 · Cited by 6

Endogenous Metabolic Disorders

Ferrante, M. A. (2007) · Elsevier eBooks · doi:10.1016/b978-141603618-0.10038-4 · Cited by 6

Complications of Pediatric Renal Transplantation

Dharnidharka, V. R., & Araya, C. E. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_67 · Cited by 6

Arguments Against the Use of Inhaled Insulin

Hirsch, I. B. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0211 · Cited by 6

Hitting the Dartboard from 40,000 Feet

Hirsch, I. B. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0190 · Cited by 6

Intracellular Delivery of Proteins and Peptides

Sarısözen, C., & Torchilin, V. P. (2016) · Drug Delivery · doi:10.1002/9781118833322.ch23 · Cited by 6

Comparing the Efficacy and Long-Term Outcomes of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Metformin, and Insulin in the Management of Type 2 Diabetes Mellitus

Khan, F., Hussain, T., Chaudhry, T. Z., Payal, F., Shehryar, A., Rehman, A., Ramadhan, A., Hayat, M. T., Dabas, M. M., & Khan, M. (2024) · Cureus · doi:10.7759/cureus.74400 · Cited by 7

Comparative Pharmacological and Pharmaceutical Perspectives on Antidiabetic Therapies in Humans, Dogs, and Cats

Kim, I., & Yun, J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091098 · Cited by 9

Préparations insuliniques au cours de la dernière décennie.

Monnier, L., & Colette, C. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30034-8 · Cited by 5

Results of glycated hemoglobin during treatment with insulin analogues dispensed in the public health system of Federal District in Brazil

Leite, E. B., Pedrosa, H. C., & Casulari, L. A. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0061-0 · Cited by 5

Comparing the efficacy, safety, and utility of intensive insulin algorithms for a primary care practice

Unger, J. (2011) · Diabetes Therapy · doi:10.1007/s13300-010-0014-4 · Cited by 5

Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes

Tauschmann, M., & Hovorka, R. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1360866 · Cited by 6

Glycemic Challenge Is Associated with the Rapid Cellular Activation of the Locus Ceruleus and Nucleus of Solitary Tract: Circumscribed Spatial Analysis of Phosphorylated MAP Kinase Immunoreactivity

Tapia, G. P., Agostinelli, L. J., Chenausky, S. D., Padilla, J. V. S., Navarro, V. I., Alagh, A., Si, G., Thompson, R. H., Balivada, S., & Khan, A. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072483 · Cited by 4

Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range

Bailey, T. S., Bode, B. W., Wang, Q., Knights, A. W., & Chang, A. M. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01400-w · Cited by 5

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes

Bergenstal, R. M., Bode, B. W., Bhargava, A., Wang, Q., Knights, A. W., & Chang, A. M. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01476-4 · Cited by 5

Hypoglycemia in Type 1 Diabetes Mellitus

Şakar, K., & Çınar, N. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004108 · Cited by 6

Pregnancy and Neonatal Outcomes in Gestational Diabetes Treated with Regular Insulin or Fast-Acting Insulin Analogues

You, J. Y., Choi, S., Roh, C., Kim, J., & Oh, S. (2015) · Gynecologic and Obstetric Investigation · doi:10.1159/000440616 · Cited by 5

Pharmacotherapies for Diabetes Management: An Update for the Practicing Clinician

Meneghini, L., & Hirsch, I. B. (2006) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2007.01.003 · Cited by 5

Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes

Giugliano, D., & Esposito, K. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812442949 · Cited by 5

Optimizing Inpatient Glycemic Control with Basal-Bolus Insulin Therapy

Pollom, R. D. (2010) · Hospital Practice · doi:10.3810/hp.2010.11.346 · Cited by 5

Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals

Lamos, E. M., Younk, L. M., Tate, D. B., & Davis, S. N. (2015) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2015.12.002 · Cited by 6

Acute Diabetic Emergencies, Hypoglycemia, and Glycemic Control

Chansky, M. E., & Haddad, G. (2008) · Elsevier eBooks · doi:10.1016/b978-032304841-5.50061-3 · Cited by 5

Glucose-sensitive materials for delivery of antidiabetic drugs

Saeed, M., & ElShaer, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102548-2.00009-3 · Cited by 5

In vitro folding of methionine‐arginine human lyspro‐proinsulin S‐sulfonate—Disulfide formation pathways and factors controlling yield

Chen, S., Adijanto, L., & Wang, N. L. (2010) · Biotechnology Progress · doi:10.1002/btpr.439 · Cited by 5

Analogues et dosages d’insuline : le cas général et le cas particulier de la glargine

Agin, A., & Sapin, R. (2010) · Médecine Nucléaire · doi:10.1016/j.mednuc.2010.07.014 · Cited by 6

Comparison of Subcutaneous Regular Insulin and Lispro Insulin in Diabetics Receiving Continuous Nutrition

Stull, M. C., Strilka, R. J., Clemens, M. S., & Armen, S. B. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815593291 · Cited by 5

Regulatory Forum Opinion Piece

Bartels, T., Wäse, K., Heinrichs, M., Stolte, M., Roome, N. O., Scherer, P., & Lindauer, K. (2016) · Toxicologic Pathology · doi:10.1177/0192623316665721 · Cited by 5

When a unit of insulin is not a unit: Detemir dosing and insulin cost in type 2 diabetes mellitus

Johnson, C. K., & Shimshi, M. (2009) · Insulin · doi:10.1016/s1557-0843(09)80017-1 · Cited by 5

Insulin Analogues

Mohn, A., Marcovecchio, M. L., & Chiarelli, F. (2005) · New England Journal of Medicine · doi:10.1056/nejm200504283521721 · Cited by 5

Pulmonary Safety and Clinical Considerations for Inhaled Insulin: A Comprehensive Review

McGill, J. B., & Mayer, O. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251396118 · Cited by 4

Choice of Long-Acting Insulin Therapy for Type 2 Diabetes

Krentz, A. J., & Sinclair, A. J. (2011) · Drugs & Aging · doi:10.2165/11597820-000000000-00000 · Cited by 4

Insulin Analogs and Glycosylated Hemoglobin Target of Less Than 7% in Type 2 Diabetes: A Systematic Review of Randomized Trials

Esposito, K., Maiorino, M. I., Bellastella, G., Chiodini, P., & Giugliano, D. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0134 · Cited by 4

Comparison of effects of insulin aspart three times a day versus insulin detemir once a day on oxidative stress in patients with type 2 diabetes

Naruse, R., Takebayashi, K., Morita, K., Aso, Y., & Inukai, T. (2011) · Endocrine Journal · doi:10.1507/endocrj.k11e-114 · Cited by 4

Type 1 Diabetes Mellitus and Exercise

Maahs, D. M., Taplin, C. E., & Fiallo-Scharer, R. V. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_14 · Cited by 4

Insulin analogues display atypical differentiative activities in skin keratinocytes

Zemler, R. S., Weingarten, G., Sarfstein, R., Laron, Z., Werner, H., & Wertheimer, E. (2015) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2014.1001856 · Cited by 4

In-Silico Trials for Glucose Control in Hospitalized Patients with Type 2 Diabetes

Choi, K., Oh, T. J., Lee, J. C., Kim, M.-J., Kim, H. C., Cho, Y. M., & Kim, S. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.2.231 · Cited by 4

Increasing Patient Acceptance and Adherence Toward Insulin

Riddle, M. C., Peters, A. L., & Funnell, M. M. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1177969 · Cited by 4

Insulin Timing: A Patient-Centered Approach To Improve Control In Type 1 Diabetes

Duran-Valdez, E., Burge, M. R., Broderick, P., Shey, L., Valentine, V., Schrader, R. M., & Schade, D. S. (2017) · Endocrine Practice · doi:10.4158/ep161265.or · Cited by 4

Modeling Ketogenesis for Use in Pediatric Diabetes Simulation

Pinnaro, C. T., Christensen, G. E., & Curtis, V. A. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819882058 · Cited by 4

Automated Adaptation of Insulin Treatment in Type 1 Diabetes

Fabris, C., Gautier, T., & Breton, M. D. (2021) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc46164.2021.9630191 · Cited by 4

Comparison of Insulin Analogs and Human Insulins: A Narrative Review

Eledrisi, M. S., & Danjuma, M. I.-M. (2023) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0043-1771027 · Cited by 4

Assessing insulin effectiveness at the end of the day: Once-daily versus twice-daily insulin glargine injection

Burge, M. R., Schroeder, E. R., & Mitchell, S. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.22032 · Cited by 4

Si l'ère des insulines semi-synthétiques et biosynthétiques nous était contée

Monnier, L., Colette, C., & Owens, D. R. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(21)00178-4 · Cited by 4

An update on the pharmacotherapy options for pediatric diabetes

Marcovecchio, M. L., & Chiarelli, F. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.874413 · Cited by 4

Optimal insulin treatment for patients with type 2 diabetes

Jermendy, G. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.009 · Cited by 4

Insulin treatment of type 2 diabetes: Considerations when converting from human insulin to insulin analogs

Griffin, S. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.679959 · Cited by 4

Stability and Glucose Regulation of FGF21 After Modified With Arginines*

Kun, H. E., Zhang, Y., Ye, X., Wang, W., Chen, R., Liu, M., Feng, M., Xu, J., & Li, D. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00007 · Cited by 4

Hypoglycemia

Cryer, P. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00034-1 · Cited by 5

Defining the benefits of euglycemia in the hospitalized patient

Braithwaite, S. S. (2007) · Journal of Hospital Medicine · doi:10.1002/jhm.155 · Cited by 4

Navigating Diabetes in Pregnancy: Critical Approaches to Mitigate Risks and Improve Outcomes for Mother and Child

Garvey, Z., Gupta, A., Taylor, N., Thirunavukkarasu, M., & Maulik, N. (2025) · Metabolites · doi:10.3390/metabo15030180 · Cited by 3

Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: The SWING study

Reaney, M. D., Cypryk, K., Tentolouris, N., Jecht, M., Cleall, S., Petzinger, U., & Koivisto, V. A. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.024 · Cited by 3

Rapid-acting insulin glulisine: an update on clinical experience

DAILEY, G. E. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.40 · Cited by 3

Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight‐based dose of insulin Aspart

Gredal, C., Rosenfalck, A. M., Dejgaard, A., & Hilsted, J. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802207982 · Cited by 3

Use of Oral Hypoglycemic and Insulin Agents in Pregnant Patients

Feldman, D. M., & Fang, Y. M. V. (2013) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2013.03.015 · Cited by 3

The Timing of Meal Insulin Administration

Schade, D. S. (2017) · Endocrine Practice · doi:10.4158/ep-2017-0073 · Cited by 3

Matrix-assisted laser desorption/ionization in-source decay mass spectrometry analysis of human insulin and insulin analogues for the identification of insulin from insulin preparations

Nagami, N., Itoh, Y., Arai, H., Iwaya, K., & Nagase, T. (2020) · Forensic Toxicology · doi:10.1007/s11419-020-00532-z · Cited by 3

Type 1 Diabetes Mellitus and Dyslipidemia

Maahs, D. M., & Eckel, R. H. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_7 · Cited by 3

The role of rapid-acting insulin analogues and inhaled insulin in type 2 diabetes mellitus

Leal, S., Herrier, R. N., & Soto, M. F. (2007) · Insulin · doi:10.1016/s1557-0843(07)80017-0 · Cited by 3

Type 1 Diabetes Mellitus and Exercise

Roberts, A. J. C., Forlenza, G. P., Maahs, D. M., & Taplin, C. E. (2017) · Contemporary diabetes · doi:10.1007/978-3-319-61013-9_19 · Cited by 3

Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes

Song, S. O., Hwang, Y., Ahn, K. J., Soo, B., Song, Y. D., Lee, D. W., & Lee, B. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0140-0 · Cited by 3

Evaluation of protocol-guided scheduled basal-nutritional-correction insulin over standard care for vascular surgery patients.

Harbin, M., Dossa, A., de Lemos, J., Drummond, I., Paty, B., & Taylor, B. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.10.004 · Cited by 4

L’allergie à l’insuline : mise au point

Waton, J. (2011) · Revue française d'allergologie · doi:10.1016/j.reval.2011.01.022 · Cited by 3

Insulin therapy in children and adolescents with diabetes

Galli‐Τsinopoulou, A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70026-2 · Cited by 4

Genomics in Pediatric Endocrinology—Genetic Disorders and New Techniques

Tenore, A., & Driul, D. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.07.001 · Cited by 3

Tratamiento de la diabetes tipo 2: revisión de las opciones y prioridades terapéuticas actuales

Arroyo, J., Caixàs, A., & Pi‐Sunyer, F. X. (2007) · Medicina Clínica · doi:10.1157/13113289 · Cited by 3

Study on preparation and unique properties of a novel insulin analogue with N-terminal Arg-4, Pro-3, Lys-2, Pro-1extension at insulin B-chain

Lu, Y., Huiyong, Z., Fang, J., Huaqian, W., Kejun, Y., Yanan, Y., Su-li, L., Xue-jun, W., Meng, Y., Rongyue, C., et al. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.06.001 · Cited by 3

Assessing the Impact of Insulin Glargine and Detemir Treatment to Serum Total IGF1 Levels in the Insulin-Naive Type 2 Diabetic Patients

Cander, S., Gül, Ö. Ö., Dizdar, O. S., Koca, N., Aydın, T., Sarandöl, E., & Ersoy, C. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0005 · Cited by 3

Complications of Renal Transplantation

Dharnidharka, V. R., & Araya, C. E. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_77 · Cited by 3

Analysis of Glulisine Crystallisation Utilising Phase Diagrams and Nucleants

Li, Y., Govada, L., Solomon, H. V., Gillis, R. B., Adams, G. G., & Chayen, N. E. (2019) · Crystals · doi:10.3390/cryst9090462 · Cited by 3

The patient with diabetes mellitus

Oats, J. J. N. (2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203092200.009 · Cited by 3

Reducing Hypoglycemia in Type 1 Diabetes: An Incremental Step Forward

Hirsch, I. B. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0174 · Cited by 3

Hypoglycemia with New Generation Basal Analog Insulins: A Descriptive Critical Review

Thrasher, M. A. J. R. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000576

Insulin analogues in the management of diabetes

Vázquez‐Carrera, M., & Silvestre, J. S. (2004) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2004.26.6.831318 · Cited by 37

The role of insulin analogues in the current treatment of diabetes mellitus

Mitrović, M., Pantelinac, P., Radosavljevic, J., Bajkin, I. A., & Todorovic-Djilas, L. (2006) · Medicinski pregled · doi:10.2298/mpns0612539m · Cited by 3

Role of New Insulin Analogs in the Management of Diabetes. A Clinical Review

Aziz, K. M. A. (2023) · Diabetes & Obesity International Journal · doi:10.23880/doij-16000269

New Insulin Analogues and Routes of Delivery

Roach, P. J. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847090-00003 · Cited by 31